BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (BGLC) is a Medical diagnostics research company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for BioNexus Gene Lab Corp. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
- Sector
- Healthcare
- Industry
- Medical diagnostics research
- Country
- Malaysia
- Exchange
- Nasdaq
- CEO
- Su-Leng Tan
- Employees
- 30
- IPO date
- 08 Jan 2021
- ISIN
- US0906283066
- Website
- bionexusgenelab.com
Frequently asked questions
Where is BioNexus Gene Lab Corp. stock listed?
BioNexus Gene Lab Corp. (BGLC) is listed on Nasdaq.